Dr. Jennifer McVean, MD, stands at the forefront of pediatric endocrinology, dedicating her career to enhancing the lives of children and families affected by diabetes and endocrine disorders. As the Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean leverages nearly two decades of clinical practice, research, and medical innovation to drive advancements in diabetes care.
Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to her practice, combining personal experience with extensive medical expertise. This dual insight has shaped her compassionate approach to patient care, emphasizing the importance of understanding the daily challenges faced by those living with diabetes.
Professional Journey and Expertise
Dr. McVean earned her medical degree from the University of Minnesota Medical School, followed by a pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held leadership, academic, and clinical positions with esteemed healthcare organizations, including the University of Minnesota, Children’s Minnesota, Gundersen Health System, Hudson Physicians, and Medtronic Diabetes. Her areas of specialization encompass:
- Type 1 Diabetes
- Pediatric Diabetes Management
- Insulin Pump Therapy
- Continuous Glucose Monitoring (CGM)
- Growth Disorders
- Thyroid Disorders
- Pediatric Endocrinology
- Diabetes Technology and Innovation
- Clinical Research and Medical Affairs Leadership
Her work has significantly contributed to advancements in automated insulin delivery systems and the adoption of diabetes technology, leading to improved outcomes for pediatric patients worldwide.
Advancements in Diabetes Technology
In her role at Medtronic Diabetes, Dr. McVean has been instrumental in the development and implementation of innovative diabetes management technologies. Notably, she co-authored a study published in the Journal of the American Medical Association (JAMA) that demonstrated the superiority of the MiniMed™ 780G system over multiple daily injections with continuous glucose monitoring for Type 1 diabetes management at one year in the ADAPT study. This research highlights the potential of automated insulin delivery systems to improve glycemic control and reduce the burden of diabetes management.
Community Involvement and Advocacy
Beyond her clinical and research endeavors, Dr. McVean is actively involved with numerous diabetes advocacy and educational organizations, including the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), ADA Camp Needlepoint, the TrialNet Research Network, and the Pediatric Endocrine Society. Her commitment to mentoring, research, education, and community outreach underscores her dedication to improving diabetes awareness, prevention, and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her contributions to pediatric diabetes care, visit her profile at Hudson Physicians.